Research output per year
Research output per year
Personal profile
Research interests
My research evolves around relevant societal and policy questions for responsible innovation in the field of Community Genetics, with a strong emphasis on valorization. Topics include: implementation of pharmacogenetics, responsible use of direct-to-consumer genetic testing, ethical and governance aspects of drug repurposing for rare diseases and roles and responsibilities in digital health.
I am:
- an inquisitive researcher with a PhD in “Translating the dynamics of genetics into health care practice”, and experience in policy-informing studies;
- skilled in implementation research, multi-stakeholder involvement, qualitative study design, motivational leadership, scientific writing, and teaching;
- aiming to create impact by building bridges, stimulating knowledge exchange, and defining strategies for optimization and change in the field of Public Health Genomics;
- secretary of the Dutch Association for Community Genetics and Public Health Genomics (NACGG); and
- program leader of the Personalized Medicine program from the Amsterdam Public Health (APH) research institute.
Specialisation
Community Genetics and Public Health Genomics, Implementation Science, Multi-stakeholder involvement, Pharmacogenetics, Direct-to-consumer genetic testing, Patient access to therapies for rare diseases, Consent for secondary use of genetic data
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Research associate, Clinical genetics, Amsterdam UMC
… → 31 Jul 2020
Researcher, National Institute for Public Health and the Environment (RIVM), Netherlands
Fingerprint
Dive into the research topics where Tessel Rigter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development Study
Onstwedder, S. M., Jansen, M. E., Cornel, M. C. & Rigter, T., 2024, In: Journal of medical Internet research. 26, 1, e47389.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile11 Downloads (Pure) -
‘Direct-to-consumer’ genetische tests in Nederland
Translated title of the contribution :Direct-to-consumer genetic tests in the Netherlands: impact on consumers and clinical practice Research output: Contribution to journal › Review article › Professional
-
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data
Roelofsen, A. H. A., Kreeftenberg, L. L., van el, C. G., Henneman, L., Rigter, T., Sie, D., Bet, P. M. & Cornel, M. C., 2025, In: Pharmacogenomics. 26, 5-6, p. 143-156 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
DNA-technologie voor de Nederlandse bevolking. Een veldconsultatie voor een DNA-visie en strategisch beleidsplan van het ministerie van VWS
Rigter, T., Jansen, M. E., Onstwedder, S. M. & Rodenburg, W., 28 Feb 2023, 60 p.Research output: Book/Report › Report › Professional
-
SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHology
van Karnebeek, C. D. M., Müller, A. R., Benkemoun, L., Boussaad, I., Cornel, M. C., IntHout, J., de Kort, M., de Oliveira Martins, S., Prigione, A., Rigter, T., Roes, K. C. B., Sanchez, A., Schipper, R., Wilkinson, M. D. & ’t Hoen, P. A. C., 1 Apr 2025, In: Molecular genetics and metabolism. 144, 4, 109073.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure)
-
Learnings from the 1+MG initiative and EHDS implementation for genomic data
Rigter, T. (Invited speaker), Shabani, M. (Speaker), Flikweert, L. (Invited speaker), Belien, J. (Invited speaker), Cervera de la Cruz, P. (Invited speaker), van El, C. (Speaker), Cornel, M. (Speaker), Ploem, C. (Speaker), Vicente, A. (Speaker) & Farina, S. (Speaker)
6 Oct 2025Activity: Talk or presentation › Invited talk › Academic
-
Talk and moderation of panel discussion on: What informs current government policies on PGx in the Netherlands? and Who is reponsible for what?
Rigter, T. (Invited speaker), Kreeftenberg, L. L. (Speaker), van El, C. (Speaker), Boccia, S. (Speaker), Vicente, A. (Speaker), Swen, J. (Speaker), van Schaik, R. (Speaker), Rutten-van Mölken, M. (Speaker), McDermott, J. (Speaker), Maliepaard, M. (Speaker), Valz Gris, A. (Speaker), Leitsalu, L. (Speaker), Kaariainen, H. (Speaker), Llerena, A. (Speaker), Sharma, V. (Speaker), Perola, M. (Speaker), Laplaza Santos, C. (Speaker), Cicchetti, A. (Speaker) & Cornel, M. (Speaker)
21 Jan 2025Activity: Talk or presentation › Invited talk › Academic
-
Empowering citizens for responsible use of direct to consumer genetic testing: The ERUDIGIT project
Rigter, T. (Speaker)
19 Sept 2024Activity: Talk or presentation › Invited talk › Professional
-
Author RIVM report։ DNA technology for the Dutch population. Field consultation for a DNA strategy and policy plan for the Ministry of Health, Welfare and Sport.
Rigter, T. (Participant)
1 Nov 2022Activity: Educational contribution / Supervising student theses, products › Supervising student products (other) › Educational
-
Netherlands Assocation of Community Genetics and Public Health Genomics (NACGG) (External organisation)
Rigter, T. (Member)
1 Jan 2022Activity: Membership › Membership of board › Academic
Press/Media
-
NTVG podcast contribution։ impact of direct-to-consumer genetic testing on society and health care consumption
19/09/2024
1 Media contribution
Press/Media: Press / Media
-
How can society regulate and afford CRISPR therapies?
29/07/2021
1 Media contribution
Press/Media: exportcomment
-
CRISPR Medicine News: How can society regulate and afford CRISPR therapies?
20/07/2021
1 Media contribution
Press/Media: interview